Holen Sie sich die Stockscreener-App
2.9716
0.32%
-0.1084
Schlusskurs vom Vortag:
$3.08
Offen:
$3.06
24-Stunden-Volumen:
6,141
Relative Volume:
0.00
Marktkapitalisierung:
$3.94M
Einnahmen:
$40,400
Nettoeinkommen (Verlust:
$-9.18M
KGV:
-11.07
EPS:
-0.2684
Netto-Cashflow:
$-5.78M
1W Leistung:
-10.50%
1M Leistung:
-39.80%
6M Leistung:
+623.72%
1J Leistung:
+120.86%
1-Tages-Spanne:
$2.985
$3.2377
1-Wochen-Bereich:
$2.985
$3.6091
52-Wochen-Spanne:
$0.071
$11.20
Jupiter Neurosciences Inc Stock (JUNS) Company Profile
Firmenname
Jupiter Neurosciences Inc
Sektor
Branche
Telefon
(561) 406-6154
Adresse
1001 NORTH US HWY 1, JUPITER
Compare JUNS vs VRTX, REGN, ARGX, MRNA, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
JUNS
Jupiter Neurosciences Inc
|
2.985 | 4.06M | 40,400 | -9.18M | -5.78M | -0.2684 |
VRTX
Vertex Pharmaceuticals Inc
|
521.74 | 134.06B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
803.48 | 83.43B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,004.21 | 63.00B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
137.49 | 56.02B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
209.88 | 44.44B | 742.00K | -1.37B | -1.07B | -7.0731 |
Jupiter Neurosciences Inc Aktie (JUNS) Neueste Nachrichten
A Tiny Psychedelic Stock Just Exploded Over 50% – Retail Traders Think $1 Is Next - Stocktwits
Jupiter Neurosciences, Inc. Common Stock (NASDAQ: JUNS) Stock Price, News & Analysis - Kalkine
Jupiter Neurosciences (Nasdaq: JUNS) lowers meeting quorum to one-third - Stock Titan
Jupiter Neurosciences, Inc. Warrants (JUNSW) Peer Comparison – Compare with Others - Value Research
Orca Capital AG Discloses 3.3% Passive Stake in Jupiter Neurosciences (NASDAQ: JUNS) - Kalkine Media
Jupiter Neurosciences (NASDAQ: JUNS) Faces Nasdaq Capital Market Delisting Over $35M Market-Value Deficiency - Kalkine Media
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com
Jupiter Neurosciences Received Notice of Delisting - TradingView
Jupiter Neurosciences (NASDAQ: JUNS) to appeal Nasdaq delisting - Stock Titan
Jupiter (JUNS) Quarterly Results: The Available Earnings Metric Delivers a Beat in Latest Trading; Latest Reaction: Shares Move Lower 8.66% for the Current SessionTax Rate Impact - vinanet.vn
Jupiter Neurosciences Raises $2.0 Million in Registered Direct Offering - Minichart
Jupiter Neurosciences Stock Surges Friday: What's Driving the Action? - Sahm
JUNS Jumps As Jupiter Neurosciences Prices Equity Deal - StocksToTrade
Jupiter Neurosciences, Inc. stock plunges 44% after spiking to $11.14 - Cryptonews.net
Jupiter Neurosciences, Inc. stock Analysis: August 2026 Volatility & Trend Review - The Cryptonomist
Best Pharmaceutical Stocks To Watch TodayAugust 21st - MarketBeat
Friday's session: most active stocks - ChartMill
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Jupiter Neurosciences Prices $2.0 Million Direct Offering - marketscreener.com
Jupiter Neurosciences Announces Pricing of $2.0 Million Registered Direct Offering - The Manila Times
Jupiter Neurosciences Jumps 59% as Volume Hits 59 Times Its Share Count - TechStock²
Jupiter Neurosciences Surges as Post-Split Float Shrinks and Traders Revisit Pipeline Expansion - Quiver Quantitative
JUNS Stock Whipsaws As New Insider Ownership Is Disclosed - timothysykes.com
JUNS Stock Draws Focus After New Insider Ownership Filing - StocksToTrade
JUNS Stock Jumps As New Insider Ownership Revealed - StocksToTrade
JUNS Stock Jumps As New Insider Ownership Comes To Light - timothysykes.com
Which stocks are moving before the opening bell on Friday? - ChartMill
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
JUNS Stock Whipsaws As New Insider Files Form 3 - StocksToTrade
Jupiter (JUNS) Trading: Posts a 3.81% Loss to $4.80 on the Day; Immediate View: the $4.56 to $5.04 Range Remains in Focus in the Current UpdateEase of Movement - vinanet.vn
Andrew Jon Cutler Net Worth (2026) - GuruFocus
Real Parkinson’s Disease Hope from Jupiter Neurosciences - Yahoo Finance
Jupiter (JUNS) Quarterly Figures: EPS Lands Above Forecast in the Latest Session; Post-Report Move: Shares Finish 3.67% Down in the Current UpdateDebt Analysis Report - Vinanet
JUNS Q4 2025 Earnings: Narrower-Than-Expected Loss Meets 6.16% Surprise but Shares Slide 12.67%Dividend Earnings Report - vinanet.vn
JUNS Q4 2025 Earnings: Narrower Loss Beats Estimates; Shares Slide 12.67%EPS Surprise History - vinanet.vn
JUNS Q4 2025 Earnings: Smaller Loss per Share Beats Estimate, But Shares Slip 12.67%Earnings Call Highlights - vinanet.vn
Jupiter Neurosciences Inc (JUNS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Jupiter Neurosciences Stock Short Interest Falls to 34.91% - Quiver Quantitative
Jupiter Neurosciences (JUNS) Tumbles 11.5% to $4.70 as Key Support Level Comes into FocusPercent Above MA - dars.gov.et
Stock Splits Calendar for: - Yahoo! Finance Canada
Calendrier des fractionnements d'actions pour: - Yahoo Finance France
JUNS|Jupiter Neurosciences Inc|Price:5.100|Chg%:-0.533 - TradingKey
Market Movers | Winners: ATTO, JUNS, XHLD | Losers: TDUP, BLLN, UWMC - Trefis
Form 8K Jupiter Neurosciences Inc For: 6 August By Investing.com - Investing.com Nigeria
Jupiter Neurosciences Announces 1-for-75 Reverse Stock Split to Regain Nasdaq Compliance - Minichart
Jupiter Neurosciences Enacts 1-for-75 Reverse Stock Split - TipRanks
Jupiter Neurosciences executes 1-for-75 reverse stock split By Investing.com - Investing.com UK
Jupiter Neurosciences grants 472,222 director options | JUNS Insider Trading - Stock Titan
Jupiter Neurosciences executes 1-for-75 reverse stock split - Investing.com
Jupiter Neurosciences, Inc. Announces 1-for-75 Reverse Stock Split Effective August 6, 2026 - Quiver Quantitative
Jupiter Neurosciences, Inc. Announces Reverse Stock Split - GlobeNewswire
Finanzdaten der Jupiter Neurosciences Inc-Aktie (JUNS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.63%
3.49%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):